PuraPharm Announces Board Composition and Roles
PuraPharm Corp. Ltd. has announced its board composition and roles, clarifying its governance structure, which may influence its strategic direction and reassure stakeholders. The latest analyst rating for PuraPharm (HK:1498) is a Hold with a price target of HK$0.50. The company, based in the Cayman Islands, operates in the pharmaceutical sector, focusing on Chinese medicine products. Current market cap stands at HK$163.9M with an average trading volume of 184,991.
The latest update is out from PuraPharm Corp. Ltd. ( (HK:1498) ).
PuraPharm Corporation Limited has announced the composition of its board of directors, detailing the roles and functions of each member. This announcement provides clarity on the governance structure of the company, which could impact its strategic direction and reassure stakeholders about its leadership stability.
The most recent analyst rating on (HK:1498) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on PuraPharm Corp. Ltd. stock, see the HK:1498 Stock Forecast page.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and production of Chinese medicine products.
Average Trading Volume: 184,991
Technical Sentiment Signal: Sell
Current Market Cap: HK$163.9M
Learn more about 1498 stock on TipRanks’ Stock Analysis page.
